What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?
Current evidence indicates no significant difference in major bleeding risk between ticagrelor and clopidogrel in patients with peripheral artery disease, though ticagrelor may have a higher incidence of minor bleeding.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24217409
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00